Algo version: 0.98b
Ondine Biomedical Inc. is listed at the LSE Exchange
Ondine Biomedical Inc. [OBI.L]
LSE Sector: Healthcare Industry:Biotechnology

Is Ondine Biomedical Inc. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Ondine Biomedical Inc. 10 years ago, but if you had invested on Monday 6th of December 2021 when the price was GBP58.00, you would have made a loss of GBP-51.22 per share or -88.31%

Yes, the average daily trading liquidity for Ondine Biomedical Inc. is GBP185 091 thousand. You should therefore be able to get in and out of your positions relatively fast.

Ondine Biomedical Inc. has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Ondine Biomedical Inc. to be medium [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.